Ringe J - Search Results

1

Final Declaration of the Asian Metaforum on the Role of Vitamin D and the Management of Osteoporosis.

Chan SP, Chen JF, Chu LW, Van DP, Hosking D, Ip TP, Koh L, Kung A, Lai NS, Lau E, Lee JK, Leewattana R, Min YK, Nghia ND, Boonsong O, Park HM, Ringe J, Setyohadi B, Shin CS, Soontrapa S, Taechakraichana N, Tanjung F, Tobing D, Tsai KS, Woo J, Yang RS. Chan SP, et al. Among authors: ringe j. Public Health Nutr. 2009 Apr;12(4):578-80. doi: 10.1017/S1368980008003224. Epub 2008 Jul 23. Public Health Nutr. 2009. PMID: 18647434

2

Declaration on Vitamin D in Osteoporosis Management: From the European Summit on the Role of Vitamin D in the Management of Osteoporosis: a MetaForum.

Hosking DJ, O'Brien M, Brandi ML, Minne HW, Mosekilde L, Ringe J, Suppan G, Walsh JB. Hosking DJ, et al. Among authors: ringe j. Clin Cases Miner Bone Metab. 2007 May;4(2):163-6. Clin Cases Miner Bone Metab. 2007. PMID: 22461218 Free PMC article. No abstract available.

3

The effect of Vitamin D on falls and fractures.

Ringe JD. Ringe JD. Scand J Clin Lab Invest Suppl. 2012;243:73-8. doi: 10.3109/00365513.2012.681965. Scand J Clin Lab Invest Suppl. 2012. PMID: 22536766 Review.

4

Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol.

Ringe JD, Schacht E. Ringe JD, et al. Rheumatol Int. 2004 Jul;24(4):189-97. doi: 10.1007/s00296-004-0454-0. Epub 2004 Jun 30. Rheumatol Int. 2004. PMID: 15232715 Review.

5

Plain vitamin D or active vitamin D in the treatment of osteoporosis: where do we stand today?

Ringe JD. Ringe JD. Arch Osteoporos. 2020 Nov 14;15(1):182. doi: 10.1007/s11657-020-00842-0. Arch Osteoporos. 2020. PMID: 33188611 Review.

6

Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.

Ringe JD, Faber H, Fahramand P, Schacht E. Ringe JD, et al. J Rheumatol Suppl. 2005 Sep;76:33-40. J Rheumatol Suppl. 2005. PMID: 16142849

7

[Drug therapy for prevention of falls and fractures].

Ringe JD. Ringe JD. Med Klin (Munich). 2006 Jun;101 Suppl 1:1-5. doi: 10.1007/s00063-006-9001-y. Med Klin (Munich). 2006. PMID: 16826362 German.

8

Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study.

Ringe JD, Farahmand P, Faber H, Dorst A. Ringe JD, et al. Rheumatol Int. 2009 Jan;29(3):311-5. doi: 10.1007/s00296-008-0689-2. Epub 2008 Sep 2. Rheumatol Int. 2009. PMID: 18762944 Clinical Trial.

9

Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trial.

Binkley N, Ringe JD, Reed JI, Ljunggren O, Holick MF, Minne HW, Liu M, Lamotta A, West JA, Santora AC. Binkley N, et al. Bone. 2009 Apr;44(4):639-47. doi: 10.1016/j.bone.2008.05.002. Epub 2008 May 15. Bone. 2009. PMID: 19185560 Clinical Trial.

10

The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

Cianferotti L, Cricelli C, Kanis JA, Nuti R, Reginster JY, Ringe JD, Rizzoli R, Brandi ML. Cianferotti L, et al. Endocrine. 2015 Sep;50(1):12-26. doi: 10.1007/s12020-015-0606-x. Epub 2015 May 1. Endocrine. 2015. PMID: 25931412 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

306 results

Search Page